MD, FRCOG
Specialises in
I have over 30 years' experience as a consultant in obstetrics and gynaecology. I have extensive experience in managing most gynaecological problems and specialise in the management of vulval conditions and vulval pain. I am registered by the British Society of Vulvo Vaginal Disease (BSVVD) as a trainer.
I am an advanced menopause specialist and trainer recognised by the British Menopause Society. I offer hormonal and non hormonal replacement therapy as well as cognitive behavioural therapy for management of problematic menopausal symptoms.
I'm keen to improve global women's health and on a voluntarily basis go to low and middle income countries to teach and train nurses and doctors. I fund raise for RCOG projects to improve women's health.
Some of the principal treatments carried out by Ms Veena Kaul at Spire include:
Gynaecology
Other treatments
COVID-19 testing or antibody tests are not available as a standalone service at Spire Methley Park Hospital.
MD Gynae / India / 1980
Master of Obstetrics and Gynaecology
DRCOG / UK / 1984
Diploma of Royal College of Obstetrics and Gynaecology
MRCOG / UK / 1988
Member of the Royal College of Obstetrics and Gynaecology
FRCOG / UK / 1998
Fellow of Royal College of Obstetrics and Gynaecology
Fellow of Royal College of Obstetricians and Gynaecologists
British Society of Vulvo Vaginal Disease (BSVVD)
British Society of Colposcopy and Cervical Pathology (BSCCP)
Mid Yorkshire Hospitals NHS Trust
I have been practising women's health for over 40 years of which these were earlier in India and then in the NHS UK. I am very much involved in improving global women's health and have raised money for the Royal College of Obstetricians and Gynaecologists (RCOG) global women's health project by climbing Mount Rinjani in Indonesia.
I have started cervical screening projects in lower and middle income countries. I frequently visit Uganda, training nurses and doctors in cervical screening and treatment. I am very keen to raise awareness of cervical cancer and screening to prevent death by cervical cancer in lower and middle income countries.